These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17825497)

  • 1. ''Iatrogenic Gilbert syndrome''--a strategy for reducing vascular and cancer risk by increasing plasma unconjugated bilirubin.
    McCarty MF
    Med Hypotheses; 2007; 69(5):974-94. PubMed ID: 17825497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum bilirubin may serve as a marker for increased heme oxygenase activity and inducibility in tissues--a rationale for the versatile health protection associated with elevated plasma bilirubin.
    McCarty MF
    Med Hypotheses; 2013 Oct; 81(4):607-10. PubMed ID: 23932761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin.
    Schwertner HA; Vítek L
    Atherosclerosis; 2008 May; 198(1):1-11. PubMed ID: 18343383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperbilirubinemia, augmentation of endothelial function, and decrease in oxidative stress in Gilbert syndrome.
    Maruhashi T; Soga J; Fujimura N; Idei N; Mikami S; Iwamoto Y; Kajikawa M; Matsumoto T; Kihara Y; Chayama K; Noma K; Nakashima A; Tomiyama H; Takase B; Yamashina A; Higashi Y
    Circulation; 2012 Jul; 126(5):598-603. PubMed ID: 22773454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of Gilbert Syndrome.
    Manandhar SR; Gurubacharya RL; Baral MR; Manandhar DS
    Kathmandu Univ Med J (KUMJ); 2003; 1(3):187-9. PubMed ID: 16388228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gilbert's syndrome--myths and reality].
    Muchová L; Kráslová I; Lenícek M; Vítek L
    Cas Lek Cesk; 2004; 143(6):375-80. PubMed ID: 15309863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention.
    McCarty MF
    Med Hypotheses; 2012 Jan; 78(1):45-57. PubMed ID: 22001128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic applications of bilirubin and biliverdin in transplantation.
    Ollinger R; Wang H; Yamashita K; Wegiel B; Thomas M; Margreiter R; Bach FH
    Antioxid Redox Signal; 2007 Dec; 9(12):2175-85. PubMed ID: 17919067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of oxidative metabolites of bilirubin in subjects with Gilbert syndrome.
    Vítek L; Kráslová I; Muchová L; Novotný L; Yamaguchi T
    J Gastroenterol Hepatol; 2007 Jun; 22(6):841-5. PubMed ID: 17565639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliverdin reductase, a major physiologic cytoprotectant, suppresses experimental autoimmune encephalomyelitis.
    Liu Y; Liu J; Tetzlaff W; Paty DW; Cynader MS
    Free Radic Biol Med; 2006 Mar; 40(6):960-7. PubMed ID: 16540391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme degradation and human disease: diversity is the soul of life.
    Shibahara S; Kitamuro T; Takahashi K
    Antioxid Redox Signal; 2002 Aug; 4(4):593-602. PubMed ID: 12230871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin.
    Jansen T; Hortmann M; Oelze M; Opitz B; Steven S; Schell R; Knorr M; Karbach S; Schuhmacher S; Wenzel P; Münzel T; Daiber A
    J Mol Cell Cardiol; 2010 Aug; 49(2):186-95. PubMed ID: 20430037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting hyperbilirubinemia in Bolivian squirrel monkeys with a Gilbert's-like syndrome.
    Cornelius CE
    Adv Vet Sci Comp Med; 1993; 37():127-47. PubMed ID: 8273512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma--pH and cofactor-specific increase in activity.
    Maines MD; Mayer RD; Erturk E; Huang TJ; Disantagnese A
    J Urol; 1999 Oct; 162(4):1467-72. PubMed ID: 10492239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategies by modulating oxygen stress in cancer and inflammation.
    Fang J; Seki T; Maeda H
    Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation and disease: protective effects of hyperbilirubinaemia.
    Basiglio CL; Arriaga SM; Pelusa F; Almará AM; Kapitulnik J; Mottino AD
    Clin Sci (Lond); 2009 Oct; 118(2):99-113. PubMed ID: 19807696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased levels of advanced glycation end-products in patients with Gilbert syndrome.
    Kalousová M; Novotny L; Zima T; Braun M; Vítek L
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(4):387-92. PubMed ID: 16309589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation.
    Ollinger R; Bilban M; Erat A; Froio A; McDaid J; Tyagi S; Csizmadia E; Graça-Souza AV; Liloia A; Soares MP; Otterbein LE; Usheva A; Yamashita K; Bach FH
    Circulation; 2005 Aug; 112(7):1030-9. PubMed ID: 16087796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enzymatic conversion of heme to bilirubin in vivo.
    Tenhunen R
    Ann Clin Res; 1976; 8 Suppl 17():2-9. PubMed ID: 1008491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting heme oxygenase-1 in vascular disease.
    Durante W
    Curr Drug Targets; 2010 Dec; 11(12):1504-16. PubMed ID: 20704550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.